Black Diamond Therapeutics (BDTX) Other Working Capital Changes (2019 - 2026)
Black Diamond Therapeutics (BDTX) posted Other Working Capital Changes of $921000.0 for Q1 2026, up 195.24% on a QoQ basis from -$967000.0 in Q4 2025, and up 202.33% year-over-year from $304630.7 in Q1 2025.
Black Diamond Therapeutics (BDTX) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Black Diamond Therapeutics' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at $921000.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 202.33% year-over-year to $921000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 1635.78% YoY) and the FY2025 annual result came in at -$3.7 million, down 11151.52% from the prior year.
- Other Working Capital Changes was $921000.0 for Q1 2026 at Black Diamond Therapeutics, up from -$967000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.9 million in Q3 2024 and bottomed at -$967000.0 in Q4 2025.
- A 5-year average of -$466529.4 and a median of -$743000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 317.21% in 2024, while the deepest fall reached 828.57% in 2024.
- Black Diamond Therapeutics' Other Working Capital Changes stood at -$743000.0 in 2022, then soared by 104.71% to $35000.0 in 2023, then tumbled by 828.57% to -$255000.0 in 2024, then slumped by 279.22% to -$967000.0 in 2025, then surged by 195.24% to $921000.0 in 2026.
- Business Quant data shows BDTX's Other Working Capital Changes at $921000.0 in Q1 2026, -$967000.0 in Q4 2025, and -$934000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 921,000.00 |
| Mar 31, 2026 | 921,000.00 |
| Mar 31, 2026 | 921,000.00 |
| Dec 31, 2025 | -967,000.00 |
| Dec 31, 2025 | -967,000.00 |
| Dec 31, 2025 | -967,000.00 |
| Sep 30, 2025 | -934,000.00 |
| Sep 30, 2025 | -934,000.00 |
| Sep 30, 2025 | -934,000.00 |
| Jun 30, 2025 | -912,000.00 |
| Jun 30, 2025 | -912,000.00 |
| Jun 30, 2025 | -912,000.00 |
| Mar 31, 2025 | -900,000.00 |
| Mar 31, 2025 | -900,000.00 |
| Mar 31, 2025 | -900,000.00 |
| Dec 31, 2024 | -255,000.00 |
| Dec 31, 2024 | -255,000.00 |
| Dec 31, 2024 | -255,000.00 |
| Sep 30, 2024 | 1.88 Mn |
| Sep 30, 2024 | 1.88 Mn |